It supports the expansion of HIV PrEP eligibility and agrees that “PrEP should be available to collect from community pharmacies”
The Royal Pharmaceutical Society...
Approved by the MHRA, Cabotegravir 600 mg long-acting injection is the first injectable treatment approved to help prevent HIV-1 infection in the UK
In a...
At the European Conference of Clinical Microbiology & Infectious Diseases (ECCMID) this year in Copenhagen, Denmark, data on a test that may detect HIV,...
Britain's GlaxoSmithKline (GSK) will receive $1.25 billion (about £921 million) from Gilead Sciences as part of a settlement between its HIV medicines unit and the...